Prana secures key patent for Parkinson’s drug PBT434 in the U.S.
Prana secures key patent for Parkinson’s drug PBT434 in the U.S.
Prana Biotechnology announced that the United States Patent and Trademark Office, USPTO, has issued a Notice of Allowance for a composition of matter patent for selected 8-hydroxy quinazolinone compounds, …